Sirona Biochem Corp. operates as a cosmetic ingredient and drug discovery company in Canada and France. The company develops programs in three areas, including diabetes, anti-inflammatories, and anti-infectives for therapeutics; anti-aging and depigmenting agents in cosmeceuticals; and biological ingredients, such as inducers and adjuvants for the biological development and preservation. It develops a sodium glucose co-transporter inhibitor for the treatment of diabetes, as well as cosmetic skin lightening agents and compounds. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone604-641-4466
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$781,017.00
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Sirona Biochem (CVE:SBM) Frequently Asked Questions
What is Sirona Biochem's stock symbol?
Sirona Biochem trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SBM."
Has Sirona Biochem been receiving favorable news coverage?
News coverage about SBM stock has been trending somewhat positive this week, InfoTrie Sentiment reports. The research group rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Sirona Biochem earned a media sentiment score of 1.5 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the stock's share price in the near future.
Who are some of Sirona Biochem's key competitors?
Some companies that are related to Sirona Biochem include Matinas BioPharma (MTNB), Matinas Biopharma (MTNB), Oxford Biodynamics (OBD), Verseon (VSN), Cynata Therapeutics (CYP), Fennec Pharmaceuticals (FRX), Covalon Technologies (COV), Neuren Pharmaceuticals (NEU), Circassia Pharmaceuticals (CIR), Tiziana Life Sciences (TILS), Mereo BioPharma Group (MPH), Equillium (EQ), Acasti Pharma (ACST), Medicure (MPH) and Immutep (IMM).
What other stocks do shareholders of Sirona Biochem own?
Who are Sirona Biochem's key executives?
Sirona Biochem's management team includes the folowing people:
- Dr. Howard J. Verrico M.D., Founder, Chairman, CEO & Sec. (Age 58)
- Mr. Christopher D. Hopton C.G.A., CFO & Director (Age 53)
- Dr. Géraldine Deliencourt-Godefroy Ph.D., Chief Scientific Officer & Director
- Ms. Michelle Seltenrich MBA, VP of Operations
- Dr. Brett A. Premack Ph.D., Scientific Consultant
How do I buy shares of Sirona Biochem?
Shares of SBM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Sirona Biochem's stock price today?
One share of SBM stock can currently be purchased for approximately C$0.19.
How big of a company is Sirona Biochem?
Sirona Biochem has a market capitalization of C$36.47 million and generates C$781,017.00 in revenue each year.
What is Sirona Biochem's official website?
How can I contact Sirona Biochem?
The company can be reached via phone at 604-641-4466.
MarketBeat Community Rating for Sirona Biochem (CVE SBM)
MarketBeat's community ratings are surveys of what our community members think about Sirona Biochem and other stocks. Vote "Outperform" if you believe SBM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBM will underperform the S&P 500 over the long term. You may vote once every thirty days.
